On Jan. 26, 2021, OraSure Technologies announced that Chronomics had selected the OMNIgene-ORAL (OME-505) saliva collection device as a component of its SARS CoV-2 PCR test. Chronomics Limited will supply its test for the United Kingdom’s ‘Test to Release for International Travel’ program. The OMNIgene-ORAL device is a product of OraSure’s DNA Genotek subsidiary.